Sometimes, pyoderma gangrenosum improves with good control of your underlying condition. But you can also get it when you’re in remission, and even after you’ve had your colon removed.

Pyoderma gangrenosum, one of the most dramatic skin conditions, was described in 1930 (Brunsting, Goeckerman, & O'Leary, 1930). PG is characterized by a centrifugal ulceration aggravated by ...

Key takeaways: Ulcerative pyoderma gangrenosum is a rare disease with no current treatment. Vilobelimab has been granted orphan drug and fast track designations by the FDA. InflaRx has initiated a ...

Pyoderma Gangrenosum: Pain Identified as Reliable Patient-Reported Outcome Doug Brunk September 21, 2023 0 ...

Phase 3 pyoderma gangrenosum trial was halted after analysis of 30 patients showed no efficacy signal. InflaRx to prioritize INF904 with key data expected in chronic spontaneous urticaria and ...

Orphan Drug Designation granted for treatment of pyoderma gangrenosum (PG) from US FDA and EMAProductive end-of-phase II meeting with FDA held for PG; dialogue ongoing related to Phase III program ...

Pyoderma gangrenosum is an inflammatory condition that starts as a rapidly enlarging, very painful ulcer, usually due to a condition like Crohn's. It is thought to affect one in 100,000 in the UK ...

Pain as a patient-reported outcome measure during the treatment of pyoderma gangrenosum may indicate whether a patient is responding to treatment, according to a research letter published in JAMA ...